New moves around Nykode's management – withdrawal of resignations

After the threat of tariffs – Novartis invests 230 billion in the USA

FDA plans to replace animal testing with AI – “Paradigm shift”

From pharmacist to life science podcaster – Magnus Lejelöv uses his voice as a tool

Korbinian Löbmann leads scientific meeting on drug formulation: High activity in the field

Tau-targeted Alzheimer's drug gets Fast Track designation in the USA

FDA’s Top Vaccine Official resigns – Issues sharp criticism of Kennedy

Success for Genmab's antibody-drug conjugate

Vaccine skeptic David Geier to lead study on link to autism

Several departures at the top at Nykode

An organ seldom in the spotlight – but utterly vital

Cancer researcher: “We can do better and reduce suffering”

Quretech granted a European patent for a new type of antibiotic

Aqilion's licensing journey: From Merck partnership to new opportunities

Positive trend for Swedish medtech exports – “We have new markets that are huge”

Career coach on salaries: “There is no right or wrong”

A tiny animal with great importance

A new scientific event in Gothenburg

Who pays for Rebecca Doe – and all of us?

The art of successful licensing – “A lot has to align”

Ukraine war fuels rise of totally resistent bacteria

Security flaw in Swedish breast cancer screening software – woman passed away

Developing rapid diagnostics for sepsis – “Every hour counts”

Investment CEO: “The Nordics are outstanding in creating successful medtech companies”

Health politician Lina Nordquist: ”I find it hard to be idle”

Björn Arvidsson: ”We must raise our gaze to find the answers of the future”

First preterm infants study – a vital step for Neola

Norway rejects national life science strategy – sees no need

Björn Arvidsson will lead research and innovation in Region Uppsala

AI detects tumor disease – via voice recording

FDA approves first non-opioid pain reliever in over 20 years

Government apoints new experts to medicine and health council

Marie Gårdmark: “What to expect from Trump’s second term?”

Life science trends 2025 – Neurology

We desire talent to come here, but are we genuinely welcoming them?

She is CSL Behring's new Nordic General Manager

The business coach: “We need to learn from our mistakes”